Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-04-03
1992-06-09
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548183, C07D27706, A61K 31425
Patent
active
051207540
ABSTRACT:
Hypoglycemic thiazolidine-2,4-dione derivatives of the formula ##STR1## wherein the dotted line represents a bond or no bond; A and dB are each independently CH or N, with the proviso that when A or B is N, the other is CH;
REFERENCES:
patent: 4287200 (1981-09-01), Kawamatsu et al.
patent: 4617312 (1986-10-01), Schnur
patent: 4703052 (1987-10-01), Eggler et al.
patent: 4725610 (1988-02-01), Meguro et al.
patent: 4775687 (1988-10-01), Meguro et al.
Sohda et al. Chem Pharm. Bull Japan, vol. 30, pp. 3580-3600 (1982).
Chemical Abstracts 80:168259k (abstracting Japan Kokai 80-64586).
Clark David A.
Goldstein Steven W.
Holland Gerald F.
Hulin Bernard
Rizzi James P.
Brokke Mervin E.
Lumb J. Trevor
Pfizer Inc.
Richardson Peter C.
Rotman Alan L.
LandOfFree
Thiazolidinedione hypoglycemic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazolidinedione hypoglycemic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolidinedione hypoglycemic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1804817